Ixekizumab Is Effective in the Treatment of Radiographic Axial Spondyloarthritis Regardless of the Level of C-Reactive Protein or Magnetic Resonance Imaging Scores

被引：0
|
作者：
Maksymowych, Walter P. [1 ]
Gallo, Gaia [2 ]
Bolce, Rebecca [2 ]
Zhao, Fangyi [2 ]
Geneus, Vladimir [2 ]
Ostergaard, Mikkel [3 ]
Tada, Kurisu [4 ]
Deodhar, Atul [5 ]
Gensler, Lianne [6 ]
机构：
[1] Univ Alberta, CARE Arthrit, Edmonton, AB, Canada
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] Univ Copenhagen, Copenhagen Ctr Arthrit Res, Copenhagen, Denmark
[4] Juntendo Univ, Sch Med, Tokyo, Japan
[5] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[6] Univ San Francisco Calif, San Francisco, CA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1521
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Effect of Secukinumab versus Adalimumab Biosimilar on Radiographic Progression in Patients with Radiographic Axial Spondyloarthritis: Results from Subgroup Analyses by Baseline Syndesmophytes and C-reactive Protein Status
    Baraliakos, Xenofon
    van der Heijde, Desiree
    Machado, Pedro
    Navarro-Compan, Victoria
    Gensler, Lianne
    Pertel, Patricia
    Quebe-Fehling, Erhard
    Readie, Aimee
    Richards, Hanno
    Poddubnyy, Denis
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1023 - 1026
  • [22] Response to Ixekizumab by C-reactive Protein Level in Patients With Radiographic Axial Spondyloarthritis: Results from the COAST-V (Biological-Naive) and COAST-W (TNF- alpha Inhibitor-Experienced) Trials at 52 Weeks
    Reveille, John
    Rahman, Proton
    Sandoval, David
    Muram, Talia
    Kronbergs, Andris
    Bolce, Rebecca
    Geneus, Vladimir
    Hunter, Theresa
    Liu-Leage, Soyi
    Rudwaleit, Martin
    Maldonado-Cocco, Jose
    van den Bosch, Filip
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1121 - 1121
  • [23] Initial C-reactive protein level: Discriminating between anti-TNF and anti-IL-17 agents as the first biologic treatment for axial spondyloarthritis?
    Goupille, Philippe
    Wendling, Daniel
    JOINT BONE SPINE, 2024, 91 (03)
  • [24] A DECREASE IN C-REACTIVE PROTEIN DOES NOT GUARANTEE FAVORABLE TREATMENT RESPONSE ENOUGH TO RETARD BONY PROGRESSION IN THE PATIENTS WITH AXIAL SPONDYLOARTHRITIS
    Seo, M. R.
    Choi, H. -J.
    Ryu, H. J.
    Lee, K. H.
    Lee, M. K.
    Baek, H. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 424 - 425
  • [25] LONG-TERM CLINICAL OUTCOMES OF CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS STRATIFIED BY BASELINE MRI AND C-REACTIVE PROTEIN STATUS
    Robinson, P.
    Maksymowych, W. P.
    Gensler, L. S.
    Rudwaleit, M.
    Hoepken, B.
    Bauer, L.
    Kumke, T.
    Kim, M.
    Deodhar, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 774 - 775
  • [26] LONG-TERM CLINICAL OUTCOMES OF CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS STRATIFIED BY BASELINE MRI AND C-REACTIVE PROTEIN STATUS
    Zochling, Jane
    Robinson, Philip C.
    Maksymowych, Walter P.
    Gensler, Lianne S.
    Rudwaleit, Martin
    Hoepken, Bengt
    Bauer, Lars
    Kumke, Thomas
    Kim, Mindy
    Deodhar, Atul
    INTERNAL MEDICINE JOURNAL, 2023, 53 : 25 - 25
  • [27] EFFICACY OF GOLIMUMAB FOR NONRADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: SUBGROUP ANALYSIS BY BASELINE MRI AND C-REACTIVE PROTEIN STATUS
    Sieper, J.
    van der Heijde, D.
    Maksymowych, W. P.
    Braun, J.
    Bergman, G.
    Curtis, S. P.
    Tzontcheva, A.
    Philip, G.
    Huyck, S.
    Dougados, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 813 - 814
  • [28] Long-Term Clinical Outcomes of Certolizumab Pegol Treatment in Patients with Active Non-Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C-Reactive Protein Status
    Robinson, Philip C.
    Maksymowych, Walter P.
    Gensler, Lianne
    Rudwaleit, Martin
    Hoepken, Bengt
    Bauer, Lars
    Kumke, Thomas
    Kim, Mindy
    Deodhar, Atul
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 808 - 810
  • [29] C-reactive protein thresholds for discriminating active disease in axial spondyloarthritis: should we lower them?
    Alonso-Castro, Sara
    del Pozo, Pablo Gonzalez
    Alvarez, Paula
    Calleja, Norma
    Burger, Stefanie
    Queiro, Ruben
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2025, 43 (03) : 472 - 476
  • [30] High-Sensitivity C-Reactive Protein and Magnetic Resonance Imaging in Occult Giant Cell Arteritis
    Mears, Katrina A.
    Feinsilber, Doron
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (08)
12345